Caribou Biosciences | IPO Presentation Deck

Slide schematic 3/3

diagram 1/1 list 1/1 title 1/1

Components 3

process bullet headline

Tools 1

CAR-T cells generally have not demonstrated broad, robust anti-tumor activity in solid tumors; Natural killer (NK) cells are allogeneic and inherently target solid tumors and metastases; Edited iNKs, derived

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

process 80%

The slide depicts a sequential manufacturing process for cell therapy.

Find anything

The diagram shows a multi-step biological process: Gene editing, two stages of differentiation, and expansion.